TG Therapeutics's market cap is currently $4.78B. The company's EPS TTM is $-0.106; its P/E ratio is ―; TG Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 233.66M	$ 2.79M	$ 6.69M	$ 152.00K	$ 152.00K
Gross Profit	$ 219.11M	$ 2.52M	$ 5.90M	$ -222.00K	$ -130.00K
Operating Income	$ 20.63M	$ -192.84M	$ -344.77M	$ -273.59M	$ -169.06M
EBITDA	$ 26.10M	$ -187.63M	$ -341.97M	$ -272.68M	$ -168.50M
Net Income	$ 12.67M	$ -203.83M	$ -355.55M	$ -285.88M	$ -179.35M
Balance Sheet
Cash & Short-Term Investments	$ 217.51M	$ 174.08M	$ 350.30M	$ 605.43M	$ 140.44M
Total Assets	$ 329.59M	$ 193.57M	$ 379.63M	$ 625.64M	$ 163.01M
Total Debt	$ 110.80M	$ 83.06M	$ 79.05M	$ 41.98M	$ 40.80M
Net Debt	$ 17.86M	$ -19.24M	$ -219.84M	$ -511.46M	$ -71.83M
Total Liabilities	$ 169.09M	$ 134.99M	$ 142.48M	$ 106.29M	$ 124.40M
Stockholders' Equity	$ 160.50M	$ -1.53B	$ -1.33B	$ 519.35M	$ -701.22M
Cash Flow
Free Cash Flow	$ -31.41M	$ -176.18M	$ -296.04M	$ -214.86M	$ -132.94M
Operating Cash Flow	$ -31.41M	$ -176.17M	$ -295.63M	$ -214.51M	$ -132.81M
Investing Cash Flow	$ -50.65M	$ -20.01M	$ -332.00K	$ -24.51M	$ -718.00K
Financing Cash Flow	$ 72.70M	$ -391.00K	$ 41.42M	$ 679.83M	$ 204.21M

Currency in USD

TG Therapeutics Earnings and Revenue History

Income Statement >

TG Therapeutics Debt to Assets

Balance Sheet >

TG Therapeutics Cash Flow

Cash Flow >

TG Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing